AzTrials
AzTrials

TraumaNCT01793428

Capillary Lactate and Transfusion Needs

An observational study of Trauma, run by University Hospital, Grenoble at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

13% of injured normotensive patients arriving in emergency unit need mass blood-transfusion of six or more units of packed Red Blood Cells. It is currently difficult to predict the need for such a mass blood-transfusion. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Trauma
What is being tested?
Capillary lactate level
How many people
120 participants
Where
1 siteFrance
Study dates
Aug 2011to Feb 2013
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adults admitted in vital emergency unit due to severe trauma based on a local severity score. Patients are normotensive

Who may be able to join

  • Adult admitted in vital emergency unit
  • Severe trauma
  • normotensive (Systolic Blood Pressure >90mmHg)
  • patient subjected to capillary haemoglobin and glucose measurements
  • patient beneficiary of social security

Who cannot join

  • pregnant woman
  • liver deficiency
  • pre-hospital transfusion
  • hypothermia below 35°C
  • protected persons according to the law
  • Nor epinephrine > 0.1gamma/kg/min

Trial locations and contacts

1 site in 1 country.

France1 site
  • Grenoble University Hospital

    La Tronche, Isere, 38700

Other trials in France

About this study

Official title: Predictive Abilities for Transfusion Needs of Capillary Lactate Measure in Emergency for Injured Normotensive Patients

13% of injured normotensive patients arriving in emergency unit need mass blood-transfusion of six or more units of packed Red Blood Cells. It is currently difficult to predict the need for such a mass blood-transfusion. Indeed hemoglobin point of care testing (hemocue) and blood pressure can be normal during the first hours despite intensive bleeding.

It's well known that blood or arterial lactate measures correlate with trauma severity but these measures are not available in a pre-hospital setting. The investigators want to test whether capillary lactate measures also correlate with trauma severity and can therefore predicts earlier transfusion needs.

Conditions
Trauma
Being tested
Capillary lactate level
Keywords
adults admitted in vital emergency unit
Medical subject headings
Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Capillary lactate levelOther

    Use of capillary sample to determine lactate level upon arrival at vital emergency unit and at 2 hours

Study groups in NCT01793428
Study groupRoleWhat they receive
Injured patient admitted in vital emergency unitNot described
Receives: Other: Capillary lactate level

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Transfusion of 6 or more units of packed Red Blood Cells (RBC)

    Measured: 48 hours

Secondary outcomes (7)
  1. arterial lactate measures

    Measured: upon arrival at the vital emergency unit

  2. injury scores (ISS,SOFA)

    Measured: 24h

  3. transfusion of 4 units of packed RBC

    Measured: 48 hours

  4. blood lactate measure

    Measured: upon arrival at vital emergency unit

  5. Intensity of medical care

    Body scan Central venous catheterisation arterial catheterisation

    Measured: upon arrival at vital emergency unit

  6. Bleeding Predictive Score

    3 questions are asked to the doctor in emergency room. Could patient be admitted directly at the CT scan ? Do you think that the patient need transfusion ? If Yes : and how many units ? Do you think that the patient will be hospitalized in an intensive care unit after the emergency room?

    Measured: upon arrival at vital emergency unit

  7. Mortality

    Measured: 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2013 (estimated)
  2. Study startAug 2011
  3. Primary completionFeb 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01793428
Sponsor's protocol ID
2012-19
Status last verified
Apr 2015
First submitted
12 Feb 2013
Last updated
3 Apr 2015
Results posted
No
Data monitoring committee
No

Publications

  • Bouzat P, Schilte C, Vinclair M, Manhes P, Brun J, Bosson JL, Payen JF. Capillary lactate concentration on admission of normotensive trauma patients: a prospective study. Scand J Trauma Resusc Emerg Med. 2016 Jun 7;24:82. doi: 10.1186/s13049-016-0272-x.

    PubMed 27267942

Questions about this trial

What is this clinical trial studying?

An observational study of Trauma, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Transfusion of 6 or more units of packed Red Blood Cells (RBC) (time frame: 48 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01793428, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in